Kiromic BioPharma

+$0.0249 (+7.55%) Today
-$0.0049 (-1.38%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRBP and other ETFs, options, and stocks.

About KRBP

Kiromic Biopharma, Inc. operates as a clinical-stage biotherapeutics company. Its platform, DIAMOND AI, discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology.

CEO
Pietro Bersani
Employees
59
Headquarters
Houston, Texas
Founded
2006

KRBP Key Statistics

Market cap
5.56M
Price-Earnings ratio
—
Dividend yield
—
Average volume
192.53K
High today
$0.37
Low today
$0.35
Open price
$0.37
Volume
95.32K
52 Week high
$11.00
52 Week low
$0.23

KRBP Earnings

-$0.76
-$0.51
-$0.25
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.48 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure